,
Jiang, Jiangang
Shu, Hongyang
Wang, Dao Wen
Hui, Rutai
Li, Chenze
Ran, Xiao
Wang, Hong
Zhang, Jing
Nie, Shaoping
Cui, Guanglin
Xiang, Dingcheng
Shao, Qun
Xu, Shengyong
Zhou, Ning
Li, Yuming
Gao, Wei
Chen, Yuguo
Bian, Yuan
Wang, Guoping
Xia, Liming
Wang, Yan
Zhao, Chunxia
Zhang, Zhiren
Zhao, Yuhua
Wang, Jianan
Chen, Shaoliang
Jiang, Hong
Chen, Jing
Du, Xianjin
Chen, Mao
Sun, Yinxian
Li, Sheng
Ding, Hu
Ma, Xueping
Zeng, Hesong
Lin, Li
Zhou, Shenghua
Ma, Likun
Tao, Ling
Chen, Juan
Zhou, Yiwu
Guo, Xiaomei
Article History
Received: 21 March 2023
Accepted: 25 July 2023
First Online: 7 February 2024
Compliance and ethics
: The formulation of this guideline was entrusted and assigned by the Chinese Society of Cardiology, undertaken by the Emergency and Critical Care Group of the Chinese Society of Cardiology, and written and discussed by senior experts and clinical front-line experts from multiple medical centers and disciplines across the country, including the Department of Cardiology, Department of Critical Care Medicine, Department of Pathology, Department of Rehabilitation, and Department of Imaging. The preparation of this guideline is supported by the Chinese Medical Association and the National Natural Science Foundation of China, and there is no commercial conflict of interest.